UNICEF promotes dissemination of international experience on immunoprevention in Ukraine
2 November 2009, Kyiv - UN Children’s Fund (UNICEF) organized discussion on international practical experience of immunoprevention during IX National Scientific Conference “Immunology questions in pediatrics”, which took place at the end of October in Kyiv. The conference gathered professors of Ukrainian medical universities, leading pediatricians, epidemiologists and family doctors from all regions of Ukraine.
UNICEF supported participation in the conference of Vitautas Usonis, one of the key European experts in immunoprevention. Professor Usonis is the Head of Vilnius University Centre of Paediatrics (Lithuania). During the debates and open discussions he lectured about vaccines quality and safety assurance, vaccines registration process in European Union countries and pertussis in modern society.
During presentations Mr. Usonis emphasized that vaccines are safe and effective measures of infectious diseases prevention. “Parents put their children at high risk of serious infectious diseases if they refuse to vaccinate. In fact they violate children’s’ rights to access for quality health services guaranteed by the UN Convention on the Rights of the Child” – stated Mr. Usonis.
Katerina Bulavinova, UNICEF medical expert, made a presentation on international tendencies of immunoprevention, diagnostics and treatment of influenza A(H1N1). Questions of seasonal and pandemic influenza were discussed by conference participants.
UNICEF supports international experience dissemination among doctors and medical experts on immunoprevention among children in the frames of the project “Restoring trust to immunization in Ukraine”.
At the beginning of October, 2009 UNICEF enabled participation of regional and national level doctors and medical experts in the 3rd International Vilnius Course “Update on Pediatric Infections” held in Vilnius (Lithuania). During the course participants received information on tick born diseases, influenza and upper respiratory tract infections, pediatric HIV/AIDS and new challenges in vaccination.